Axa wins final regulatory approval for $15.3bn XL deal
  • X
  • LinkedIn
  • Email
  • Show more sharing options
  • X
  • LinkedIn
  • Email
  • Print
  • Free trial
  • Log in

Axa wins final regulatory approval for $15.3bn XL deal

Ted Bunker
11 September 2018
  • X
  • LinkedIn
  • Email
  • Show more sharing options
  • X
  • LinkedIn
  • Email
  • Print
700-x-410-crop-of-axa-exec-rings-opening-bell-on-nyse-at-10-may-ipo-nyse-tweet.jpg

Axa plans to close its $15.3bn acquisition of XL Group on Wednesday after receiving final regulatory approvals for that step, the company said today.

Subscribers, log in here:

Fuel a smarter strategy with our actionable market intelligence

      • Gain a competitive edge and accelerate decision-making
      • Be empowered by insights that transform confusion to clarity
      • Uncover growth opportunities and prepare for potential threats
      • Fuel a smarter strategy for business growth
Request a free trial Already a subscriber? Log in now

Topics

News Axa M&A
TB
Ted Bunker
Gift this article